On March 1, 2013, the first subject completed their final (one-year) follow-up interview in our ongoing relapse study of MDMA-assisted psychotherapy for PTSD in three subjects whose symptoms returned several years after participating in our completed U.S. proof of principle study. Also on March 1, the second subject completed their two-month follow-up interview.
